LeonaBio (LONA) Cash & Current Investments (2019 - 2026)

LeonaBio (LONA) has 8 years of Cash & Current Investments data on file, last reported at $67.7 million in Q1 2026.

• Cash & Current Investments for Q1 2026 came in at $67.7 million, up 84.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $67.7 million (up 84.56% YoY), and the FY2025 annual result was $88.3 million, up 72.27% from the prior year.
• Cash & Current Investments slipped to $67.7 million in Q1 2026 per LONA's latest filing, from $88.3 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $263.5 million in Q1 2022 and troughed at $25.2 million in Q3 2025.
• A 5-year average of $130.0 million and a median of $122.1 million in 2024 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2025 and 2026: Cash & Current Investments tumbled 69.96% in 2025, then soared 84.56% in 2026.
• A 5-year view of Cash & Current Investments shows it stood at $200.3 million in 2022, then declined by 26.42% to $147.4 million in 2023, then sank by 65.22% to $51.3 million in 2024, then jumped by 72.27% to $88.3 million in 2025, then declined by 23.38% to $67.7 million in 2026.
• Business Quant data shows LONA's Cash & Current Investments at $67.7 million in Q1 2026, $88.3 million in Q4 2025, and $25.2 million in Q3 2025.